|
KIAA1704 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96869999999194E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.10299999999975E-05 |
| Normal-vs-Stage2 |
7.132200E-02 |
| Normal-vs-Stage3 |
2.264700E-03 |
| Normal-vs-Stage4 |
1.040900E-03 |
| Stage1-vs-Stage2 |
5.726400E-01 |
| Stage1-vs-Stage3 |
7.719400E-01 |
| Stage1-vs-Stage4 |
5.905800E-01 |
| Stage2-vs-Stage3 |
5.175800E-01 |
| Stage2-vs-Stage4 |
4.153600E-01 |
| Stage3-vs-Stage4 |
7.394800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21299999999936E-05 |
| Normal-vs-AfricanAmerican |
2.044800E-03 |
| Normal-vs-Asian |
3.376100E-03 |
| Caucasian-vs-AfricanAmerican |
7.585800E-01 |
| Caucasian-vs-Asian |
4.339200E-01 |
| AfricanAmerican-vs-Asian |
3.756000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.18359999995632E-06 |
| Normal-vs-Female |
7.656300E-02 |
| Male-vs-Female |
1.915810E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.230000E-04 |
| Normal-vs-Extreme_Weight |
1.58816999999978E-05 |
| Normal-vs-Obese |
4.203800E-03 |
| Normal-vs-Extreme_Obese |
1.347860E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.926400E-01 |
| Normal_Weight-vs-Obese |
3.107600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.679000E-01 |
| Extreme_Weight-vs-Obese |
1.160030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.947200E-01 |
| Obese-vs-Extreme_Obese |
5.800200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.52770000000047E-05 |
| Normal-vs-Age(41-60Yrs) |
6.556800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.61998999999025E-05 |
| Normal-vs-Age(81-100Yrs) |
2.229200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.685900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.364800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.606200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.599600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.045050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.648600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.44420000000179E-05 |
| Normal-VS-Type2 PRCC |
1.028460E-04 |
| Normal-VS-KIRP CIMP |
7.361000E-04 |
| Normal-VS-Unclassified PRCC |
1.072160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.594600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.336400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.849200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.555200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.828990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.358400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.04209999810479E-08 |
| Normal-vs-N1 |
2.536500E-02 |
| Normal-vs-N2 |
5.199700E-04 |
| N0-vs-N1 |
4.502200E-02 |
| N0-vs-N2 |
2.284400E-01 |
| N1-vs-N2 |
1.059560E-01 |
|
|
